Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies
Subscribe To Our Newsletter & Stay Updated
